Internal Medicine, Rheumatology · Richmond, KY
NPI
1023058302
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2130 Lexington Rd Ste A-B
Richmond, KY, 40475
Phone (859) 623-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
37,725 services
Medicare patients, 2024
328
Average age 69
Drug cost, 2024
$11.9M
10,002 prescriptions
Company payments, 2025
$2,635
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mansoor Ahmed was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 36,000 times for 11 patients. In total Mansoor Ahmed billed 37,725 services in 14 codes, and Medicare paid $195K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 36,000 | 11 | $3.61 | $130K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 601 | 58 | $0.09 | $51.41 |
| 99214 Office E&M - Established | Office | 574 | 280 | $85.33 | $49K |
| 96372 Injection Administration | Office | 262 | 71 | $10.24 | $2,682 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 104 | 22 | $0.69 | $72.08 |
| 99204 Office E&M - New | Office | 64 | 64 | $114.77 | $7,346 |
| 99213 Office E&M - Established | Office | 61 | 48 | $60.00 | $3,660 |
| 20610 Joint Injection | Office | 27 | 21 | $40.37 | $1,090 |
| 99203 Office E&M - New | Office | 13 | 13 | $65.37 | $850 |
By year: 2022 $218K for 20,194 services; 2023 $186K for 31,272 services; 2024 $195K for 37,725 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mansoor Ahmed prescribed most often to Medicare patients was Prednisone, with 1,932 prescriptions and refills. In total Mansoor Ahmed wrote 10,002 Medicare prescriptions that cost $11.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,932 | 2,459 | 615 | $6,391 |
| Methotrexate Methotrexate Sodium | 1,471 | 2,110 | 330 | $17K |
| Hydroxychloroquine Sulfate Generic | 1,218 | 1,820 | 304 | $17K |
| Leflunomide Generic | 819 | 1,324 | 227 | $42K |
| Tizanidine Hcl Generic | 469 | 662 | 128 | $2,348 |
| Duloxetine Hcl Generic | 406 | 554 | 119 | $3,758 |
| Humira(Cf) Pen Adalimumab | 380 | 382 | 51 | $2.7M |
| Enbrel Mini Etanercept | 335 | 335 | 55 | $2.4M |
| Rinvoq Upadacitinib | 316 | 318 | 55 | $2.0M |
| Pregabalin Generic | 261 | 285 | 43 | $9,213 |
| Meloxicam Generic | 258 | 334 | 74 | $625 |
| Orencia Clickject Abatacept | 200 | 200 | 36 | $1.1M |
| Gabapentin Generic | 170 | 197 | 26 | $2,269 |
| Diclofenac Sodium Generic | 152 | 194 | 52 | $3,636 |
| Alendronate Sodium Generic | 151 | 246 | 45 | $659 |
Brand drugs: 1,720 claims; generic drugs: 8,265 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mansoor Ahmed $2,635 ($2,635 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $474.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 39 | $474 |
| UCB, Inc. UCB.BR | 27 | $400 |
| Janssen Biotech, Inc. JNJ | 15 | $337 |
| Abbvie Inc. ABBV | 21 | $304 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $272 |
| ANI Pharmaceuticals, Inc. ANIP | 15 | $168 |
| Mallinckrodt Hospital Products Inc. | 4 | $111 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $95.1 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $61.66 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $57.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.